OBJECTIVE: To evaluate pelvic artery embolisation (PAE) in the emergency management of intractable postpartum haemorrhage (PPH) associated with placenta accreta (PA). METHODS: Forty such patients (PAE for PPH/PA) were retrospectively reviewed. Medical records were reviewed regarding the delivery and PAE procedure. Follow-up gynaecological outcomes after PAE were obtained by telephone interviews. RESULTS: Technical success was achieved in all women (100 %). The initial clinical success rate was 82.5 % (33/40). Three patients with PA underwent hysterectomy after PAE failed to stop the bleeding within 24 h after the embolisation. The other three patients underwent re-embolisation (two patients underwent re-embolisation on the next day and one ...
AbstractAimTo evaluate the potential role, efficacy, and complications of endovascular management of...
Background: Although the effects of uterine arterial embolization (UAE) for the control of post-part...
PURPOSE: To evaluate outcomes of patients with placenta accreta spectrum (PAS) disorders who underwe...
Objective: To evaluate the efficacy of uterine artery embolization (UAE) in the treatment of postpar...
Background/purposeTo assess the risk factors for intractable and controllable postpartum hemorrhage ...
Arterial embolisation (AE) plays a major role in current practice in the management of postpartum ha...
Background: Development of pelvic artery embolization, introduced in 1979, has revolutionized the pr...
Objective: To evaluate the efficacy and safety of arterial embolization for prophylaxis and treatmen...
PURPOSE: To evaluate the efficacy and safety of transcatheter arterial embolization of the pelvic ar...
Purpose of investigation: To evaluate the rate of all postpartum hemorrhages (PPHs) treated with ute...
International audienceBACKGROUND: The guidelines advise arterial embolization in case of post-partum...
Objective: The object of this study was to evaluate the indications, effectiveness and complications...
Background: Postpartum hemorrhage is the leading cause of severe maternal morbidity and death. A pro...
Uterine artery embolization is a highly specialised and efficacious method that can be used prophyla...
Background: Postpartum hemorrhage is the leading cause of severe maternal morbidity and death. A pro...
AbstractAimTo evaluate the potential role, efficacy, and complications of endovascular management of...
Background: Although the effects of uterine arterial embolization (UAE) for the control of post-part...
PURPOSE: To evaluate outcomes of patients with placenta accreta spectrum (PAS) disorders who underwe...
Objective: To evaluate the efficacy of uterine artery embolization (UAE) in the treatment of postpar...
Background/purposeTo assess the risk factors for intractable and controllable postpartum hemorrhage ...
Arterial embolisation (AE) plays a major role in current practice in the management of postpartum ha...
Background: Development of pelvic artery embolization, introduced in 1979, has revolutionized the pr...
Objective: To evaluate the efficacy and safety of arterial embolization for prophylaxis and treatmen...
PURPOSE: To evaluate the efficacy and safety of transcatheter arterial embolization of the pelvic ar...
Purpose of investigation: To evaluate the rate of all postpartum hemorrhages (PPHs) treated with ute...
International audienceBACKGROUND: The guidelines advise arterial embolization in case of post-partum...
Objective: The object of this study was to evaluate the indications, effectiveness and complications...
Background: Postpartum hemorrhage is the leading cause of severe maternal morbidity and death. A pro...
Uterine artery embolization is a highly specialised and efficacious method that can be used prophyla...
Background: Postpartum hemorrhage is the leading cause of severe maternal morbidity and death. A pro...
AbstractAimTo evaluate the potential role, efficacy, and complications of endovascular management of...
Background: Although the effects of uterine arterial embolization (UAE) for the control of post-part...
PURPOSE: To evaluate outcomes of patients with placenta accreta spectrum (PAS) disorders who underwe...